Similar articles

• Thalidomide induction of bone marrow transplantation tolerance.

  Vogelsang GB, Hess AD, Gordon G, Brundrette R, Santos GW. Vogelsang GB, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2658-61. Transplant Proc. 1987. PMID: 3547944 No abstract available.
• [Thalidomide and graft verses host disease: basis for a new indication and side effects].

  López Gil JA. López Gil JA. Med Clin (Barc). 1992 Oct 31;99(14):545-8. Med Clin (Barc). 1992. PMID: 1434991 Review. Spanish. No abstract available.
• Thalidomide back in good graces--seems to help GVHD patients.

  [No authors listed] [No authors listed] Oncology (Williston Park). 1988 Sep;2(9):29. Oncology (Williston Park). 1988. PMID: 3275064 No abstract available.
• Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.

  Cole CH, Rogers PC, Pritchard S, Phillips G, Chan KW. Cole CH, et al. Bone Marrow Transplant. 1994 Dec;14(6):937-42. Bone Marrow Transplant. 1994. PMID: 7711671 Clinical Trial.
• Thalidomide--the need for a new clinical evaluation of an old drug.

  Ehninger G, Eger K, Stuhler A, Schuler U. Ehninger G, et al. Bone Marrow Transplant. 1993;12 Suppl 3:S26-8. Bone Marrow Transplant. 1993. PMID: 8124253 Review.